Serum Hepatocyte Growth Factor Predicts Outcomes in Non‐Acetaminophen Drug‐Induced Acute Liver Failure
Tao Wang, Silvia M Bacot, Kamai Patterson, Devira Friedman, Caroline Taylor, Huixiao Hong, Jie Liu, Mark I Avigan, Paul Hayashi, Jody A Rule, William M Lee, Jorge Rakela, Gerald M Feldman, Minjun Chen · 2026
Read Serum Hepatocyte Growth Factor Predicts Outcomes in Non‐Acetaminophen Drug‐Induced Acute Liver Failure by Tao Wang, Silvia M Bacot, Kamai Patterson, Devira Friedman, Caroline Taylor, Huixiao Hong, Jie Liu, Mark I Avigan, Paul Hayashi, Jody A Rule, William M Lee, Jorge Rakela, Gerald M Feldman, Minjun Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13628146.txt.
Description
Tao Wang and thirteen co-authors tested a growth factor's power to foretell outcomes in sudden liver failure caused by drugs, in this 2026 study. The group studied excludes the common painkiller cause, where prognosis rules differ. Seventy-nine patients and nineteen healthy donors gave blood for a panel of repair and inflammation markers.
The growth factor, HGF, ran far higher in patients and climbed with injury severity. It peaked in those who died or needed a transplant. Standard liver scores also predicted well, while inflammation markers mostly did not. The team folded the factor into a three-part score and set it against the field's standard model. The authors pitch blood HGF as a prognostic sign in this group.
Catalog record
| CREATOR | Tao Wang, Silvia M Bacot, Kamai Patterson, Devira Friedman, Caroline Taylor, Huixiao Hong, Jie Liu, Mark I Avigan, Paul Hayashi, Jody A Rule, William M Lee, Jorge Rakela, Gerald M Feldman, Minjun Chen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |